M

Mary Dowd

Creative Research

Publishes on Human auditory perception and evaluation, Developmental Biology and Gene Regulation, Angiogenesis and VEGF in Cancer. 10 papers and 5.2k citations.

10Publications
5.2kTotal Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

IGF-I is required for normal embryonic growth in mice.
Cited by 806Open Access

IGF-I is a pleiotropic hormone reported to affect linear growth, glucose metabolism, organ homeostasis, and the immune and neurologic systems. In contrast to IGF-II, IGF-I is expressed at low levels embryonically and has been thought to be more important for postnatal growth and development. To investigate the role of IGF-I in normal development we generated mice with an inactive IGF-I gene by homologous recombination in ES cells. Heterozygous mice are healthy and fertile, but they are 10-20% smaller than wild-type littermates and have lower than normal levels of IGF-I. The size reduction is attributable to a decrease in organs and muscle and bone mass. However, all tissues appear histologically normal. At birth homozygous mutant mice (IGF-I-/-) are < 60% body weight of wild type. Greater than 95% of IGF-I-/- pups die perinatally. Histopathology is characterized by underdevelopment of muscle tissue. Lungs of late embryonic and neonates also appeared less organized with ill-defined alveolae. IGF-I appears to be essential for correct embryonic development in mice.

Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin.
Frédéric J. de Sauvage, Karen Carver-Moore, Shiuh-Ming Luoh et al.|The Journal of Experimental Medicine|1996
Cited by 439Open Access

Thrombopoietin (TPO) has recently been cloned and shown to regulate megakaryocyte and platelet production by activating the cytokine receptor c-mpl. To determine whether TPO is the only ligand for c-mpl and the major regulator of megakaryocytopoiesis, TPO deficient mice were generated by gene targeting. TPO-/- mice have a >80% decrease in their platelets and megakaryocytes but have normal levels of all the other hematopoietic cell types. A gene dosage effect observed in heterozygous mice suggests that the TPO gene is constitutively expressed and that the circulating TPO level is directly regulated by the platelet mass. Bone marrow from TPO-/- mice have decreased numbers of megakaryocyte-committed progenitors as well as lower ploidy in the megakaryocytes that are present. These results demonstrate that TPO alone is the major physiological regulator of both proliferation and differentiation of hematopoietic progenitor cells into mature megakaryocytes but that TPO is not critical to the final step of platelet production.

True North
Mary Dowd|The Permanente Journal|2008
Cited by 0

Mary Dowd, MD Fall 2008 - Volume 12 Number 4 Men at the jail come in three varieties: lost boys, cool dudes, old wrecks The lost boys have just awoken from their trance of heroin or coke, or alcohol and oxy&